Expansion of platform physiologically-based pharmacokinetic model for monoclonal antibodies towards different preclinical species: cats, sheep, and dogs-Reference-Cited by-同舟云学术

Expansion of platform physiologically-based pharmacokinetic model for monoclonal antibodies towards different preclinical species: cats, sheep, and dogs

Published:2023-11-10 Issue: Volume: Page:
ISSN:1567-567X
Container-title:Journal of Pharmacokinetics and Pharmacodynamics
language:en
Short-container-title:J Pharmacokinet Pharmacodyn

Author:

Huang Hsien-Wei,Wu Shengjia,Chowdhury Ekram A.,Shah Dhaval K.

Funder

Center for Protein Therapeutics, University at Buffalo

National Institute of General Medical Sciences

National Institute of Allergy and Infectious Diseases

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s10928-023-09893-5.pdf

Reference61 articles.

1. Liu JK (2014) The history of monoclonal antibody development - Progress, remaining challenges and future innovations. Ann Med Surg (Lond) 3(4):113–116. https://doi.org/10.1016/j.amsu.2014.09.001

2. Paoloni M, Khanna C (2008) Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 8(2):147–156. https://doi.org/10.1038/nrc2273

3. LeBlanc AK, Mazcko CN (2020) Improving human cancer therapy through the evaluation of pet dogs. Nat Rev Cancer 20(12):727–742. https://doi.org/10.1038/s41568-020-0297-3

4. Bustamante-Córdova L, Melgoza-González EA, Hernández J (2018) Recombinant antibodies in veterinary medicine: an update. Front Vet Sci 5:175. https://doi.org/10.3389/fvets.2018.00175

5. DuBourdieu D (2019) Colostrum antibodies, egg antibodies and monoclonal antibodies providing passive immunity for animals. In: Gupta RC, Srivastava A, Lall R (eds) Nutraceuticals in veterinary medicine. Springer, Cham, pp 245–257